FRS2 Antibodies

Santa Cruz Biotechnology provides a broad selection of FRS2 monoclonal antibodies for studying FRS2, a critical adaptor protein involved in various signaling pathways, particularly those related to fibroblast growth factor (FGF) and nerve growth factor (NGF). FRS2 monoclonal antibodies enable multiple research applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FRS2 plays a significant role in mediating cellular responses to growth factors, influencing processes such as cell proliferation, differentiation, and survival. The involvement of FRS2 in signaling pathways makes it a key player in developmental biology and cancer research. Understanding FRS2 function and regulation provides valuable insights into disease mechanisms and potential therapeutic strategies. Researchers can utilize FRS2 monoclonal antibodies to examine protein expression patterns across different tissues and cellular conditions. Advanced detection methods using horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates allow for versatile experimental approaches. Santa Cruz Biotechnology monoclonal antibodies for FRS2 support researchers worldwide in advancing scientific knowledge and developing innovative therapeutic solutions.